Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for March 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
CDC: Many Adults Not Receiving Sexual Risk Assessments
THURSDAY, March 29, 2018 (HealthDay News) -- Less than half of women and a quarter of men with recent sexual activity receive sexual risk assessment, according to a March data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.
Abstract/Full Text
Non-Targeted HIV Testing in ER Acceptable to Patients
THURSDAY, March 29, 2018 (HealthDay News) -- A non-targeted HIV testing approach in a South African emergency department is acceptable to patients and reveals a high HIV prevalence, including undiagnosed cases, according to a study published online March 13 in PLOS ONE.
Abstract/Full Text
Novel Interstitium Has Been Identified in Human Tissues
THURSDAY, March 29, 2018 (HealthDay News) -- A previously unrecognized interstitium has been identified in human tissues, according to a study published online March 27 in Scientific Reports.
Abstract/Full Text
EHR Usability Contributes to Possible Patient Harm Events
TUESDAY, March 27, 2018 (HealthDay News) -- Electronic health record (EHR) usability may contribute to possible patient harm events, according to a research letter published in the March 27 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Ethical Duties ID'd for Short-Term Global Health Experiences
MONDAY, March 26, 2018 (HealthDay News) -- In a position paper published online March 27 in the Annals of Internal Medicine, ethical obligations have been detailed for physicians participating in short-term global health experiences (STEGHs).
Abstract/Full Text
For Those With HIV, Symptom Burden Higher in Women
MONDAY, March 26, 2018 (HealthDay News) -- The burden of two of the most common symptoms in patients living with HIV -- fatigue and muscle aches/joint pains -- is higher in women, according to a study published online March 5 in Menopause.
Abstract/Full Text (subscription or payment may be required)
Lean Approach May Help Tackle Burnout in Health Care Providers
FRIDAY, March 23, 2018 (HealthDay News) -- The Lean approach, which emphasizes reducing waste and improving customer value by focusing on the big picture, can be used to address physician burnout, according to a report published in Medical Economics.
Abstract/Full Text
Unique Risks Associated With Texting Medical Orders
THURSDAY, March 22, 2018 (HealthDay News) -- Despite the popularity, convenience, and speed of texting medical orders, there are unique and alarming risks associated with the practice, according to a report published in Drug Topics.
Abstract/Full Text
Blueprint Being Developed to Address Physician Burnout
WEDNESDAY, March 21, 2018 (HealthDay News) -- A new, three-pronged approach is being applied to develop a blueprint for addressing physician burnout, according to a report published in Medical Economics.
Abstract/Full Text
HIV Incidence Down in All Except Men Who Have Sex With Men
WEDNESDAY, March 21, 2018 (HealthDay News) -- From 2008 to 2015, there was a decrease in modeled HIV incidence in all transmission risk groups except men who have sex with men (MSM), according to research published online March 20 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Personal Health Info Found in Recycling at Five Hospitals
TUESDAY, March 20, 2018 (HealthDay News) -- A considerable amount of personal health information (PHI) and personally identifiable information (PII) was found in the recycling at five Canadian teaching hospitals, according to a research letter published in the March 20 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment nay be required)
Prior Authorization Negatively Impacts Clinical Outcomes
MONDAY, March 19, 2018 (HealthDay News) -- The burdens associated with prior authorization (PA) are high and include a negative impact on clinical outcomes, reported by 92 percent of physicians, according to the results of a survey conducted for the American Medical Association (AMA).
Press Release
Survey
Drug Copayments Often Exceed Prescription Drug Costs
WEDNESDAY, March 14, 2018 (HealthDay News) -- Drug copayments frequently exceed prescription drug costs, with overpayments affecting 23 percent of all prescriptions, according to a research letter published in the March 13 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
U.S. Spends Twice As Much for Similar Health Care Utilization
TUESDAY, March 13, 2018 (HealthDay News) -- Spending on health care is much higher in the United States than other high-income countries, but utilization rates are similar, according to a study published in the March 13 issue of the Journal of the American Medical Association.
Abstract/Full Text
Editorial 1 (subscription or payment may be required)
Editorial 2 (subscription or payment may be required)
Editorial 3 (subscription or payment may be required)
Editorial 4 (subscription or payment may be required)
Three-Pronged Approach Can Improve Physician Engagement
MONDAY, March 12, 2018 (HealthDay News) -- The three-pronged approach implemented by one practice successfully improved physician engagement, according to an article published in Medical Economics.
Abstract/Full Text
Doctors Facing Challenge to Help Needy While Protecting Practices
FRIDAY, March 9, 2018 (HealthDay News) -- Physicians are increasingly being challenged to protect their practice finances while helping patients without insurance, according to an article published in Medical Economics.
Abstract/Full Text
FDA Approves New Medication for Drug-Resistant HIV
TUESDAY, March 6, 2018 (HealthDay News) -- Trogarzo (ibalizumab-uiyk) has been approved by the U.S. Food and Drug Administration to treat adult patients living with HIV who have not responded to other antiretroviral medications.
More Information
